Pharmacogenomics--ready for prime time?
作者： Susan B. Shurin , Elizabeth G. Nabel
DOI: 10.1056/NEJME0800801
关键词:
摘要: It cannot be emphasized too strongly that treatment of each patient is a highly individualized matter. — FDA-approved labeling for warfarin (Coumadin) NDA 9-218/5-105 Pharmacogenomics receiving great deal attention in scientific circles and, increasingly, the popular press because promise personalized medicine. Short being able to cure an illness or prevent one, every clinician's dream offer patients precisely targeted drug at calibrated dose address specific ailment and do so without wreaking havoc on rest body. We have ample reason . . .
sci-hub.se 参考文章(7)
Charles Eby, Paul Milligan, Gerald Banet, Jill Duncan, Howard McLeod, Brian Gage, Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin. Thrombosis and Haemostasis. ,vol. 91, pp. 87- 94 ,(2003) , 10.1160/TH03-06-0379
Harumi Takahashi, Grant R. Wilkinson, Edith A. Nutescu, Takashi Morita, Marylyn D. Ritchie, Maria G. Scordo, Vittorio Pengo, Martina Barban, Roberto Padrini, Ichiro Ieiri, Kenji Otsubo, Toshitaka Kashima, Sosuke Kimura, Shinichi Kijima, Hirotoshi Echizen, Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans Pharmacogenetics and Genomics. ,vol. 16, pp. 101- 110 ,(2006) , 10.1097/01.FPC.0000184955.08453.A8
Mark J. Rieder, Alexander P. Reiner, Brian F. Gage, Deborah A. Nickerson, Charles S. Eby, Howard L. McLeod, David K. Blough, Kenneth E. Thummel, David L. Veenstra, Allan E. Rettie, Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose. The New England Journal of Medicine. ,vol. 352, pp. 2285- 2293 ,(2005) , 10.1056/NEJMOA044503
Matthew D Mailman, Michael Feolo, Yumi Jin, Masato Kimura, Kimberly Tryka, Rinat Bagoutdinov, Luning Hao, Anne Kiang, Justin Paschall, Lon Phan, Natalia Popova, Stephanie Pretel, Lora Ziyabari, Moira Lee, Yu Shao, Zhen Y Wang, Karl Sirotkin, Minghong Ward, Michael Kholodov, Kerry Zbicz, Jeffrey Beck, Michael Kimelman, Sergey Shevelev, Don Preuss, Eugene Yaschenko, Alan Graeff, James Ostell, Stephen T Sherry, The NCBI dbGaP database of genotypes and phenotypes. Nature Genetics. ,vol. 39, pp. 1181- 1186 ,(2007) , 10.1038/NG1007-1181
, A second generation human haplotype map of over 3.1 million SNPs Nature. ,vol. 449, pp. 851- 861 ,(2007) , 10.1038/NATURE06258
Ute I. Schwarz, Marylyn D. Ritchie, Yuki Bradford, Chun Li, Scott M. Dudek, Amy Frye-Anderson, Richard B. Kim, Dan M. Roden, C. Michael Stein, Genetic determinants of response to warfarin during initial anticoagulation. The New England Journal of Medicine. ,vol. 358, pp. 999- 1008 ,(2008) , 10.1056/NEJMOA0708078
Mitchell K Higashi, David L Veenstra, L Midori Kondo, Ann K Wittkowsky, Sengkeo L Srinouanprachanh, Fred M Farin, Allan E Rettie, Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy. JAMA. ,vol. 287, pp. 1690- 1698 ,(2002) , 10.1001/JAMA.287.13.1690